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Background
Multimorbidity defined as the ‘‘the coexistence of two or more
chronic diseases’’ in one individual, is increasing in prevalence
globally. The aim of this study was to compare the prevalence
of multimorbidity across middle-income countries (MICs) and
high-income countries (HICs), and investigate patterns by age
and socio-economic status (SES).
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Methods
Chronic disease data from 28 countries of the World Health
Survey (2003) were extracted and inter-country socio-
economic differences were examined using gross domestic
product (GDP). Regression analyses were applied to examine
associations of SES with multimorbidity by region adjusted for
age and sex distributions.
Results
The mean world standardized prevalence was 7.8% (95%
CI = 7.79–7.83). In all countries, multimorbidity increased
significantly with age. A positive but non–linear relationship
was found between country GDP and multimorbidity
prevalence. Trend analyses of multimorbidity by SES suggest
that there are intergenerational differences, with a more inverse
SES gradient for younger adults compared to older adults.
Higher SES was significantly associated with a decreased risk of
multimorbidity in the all-region analyses.
Conclusion
Multimorbidity is a global phenomenon, not just affecting
older adults in HICs. Policy makers worldwide need to address
these health inequalities, and support the complex service
needs of a growing multimorbid population.
Key messages
 National multimorbidity prevalence estimates are positively
associated with GDP per capita, although the relationship is
non-linea.
 Higher socioeconomic status is associated with a decreased
risk of multimorbidity in the all-region analyses
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